aDepartment of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
bDepartment of Orthopedic Surgery, University of Vermont Medical Center, Burlington, VT
cDepartment of Neurosurgery, Mayo Clinic Hospital, Rochester Minnesota
dSpine Institute of Louisiana, Shreveport, LA
eFlorida Orthopedic Associates, Orange City, FL.
Address correspondence and reprint requests to John H. Chi, MD, MPH, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115; E-mail: [email protected]
Received 27 April, 2020
Revised 2 July, 2020
Accepted 6 August, 2020
The device(s)/drug(s) that is/are the subject of this manuscript is/are being evaluated as part of an ongoing food and drug administration (FDA)-approved investigational protocol (IDE) or corresponding national protocol as a novel device for performing minimally invasive interbody fusion.
Spineology funds were received in support of this work.
Relevant financial activities outside the submitted work: consultancy, grants.
